Nutra Pharma Company Top Management
NPHC Stock | USD 0.0001 0.00 0.00% |
Nutra Pharma employs about 4 people. The company is managed by 4 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Evaluation of Nutra Pharma's management performance can provide insight into the firm performance.
Neil Roth Insider Inc Diagnostics |
Dale MBA Insider Chief Officer |
Nutra |
Nutra Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (1.1323) % which means that it has lost $1.1323 on every $100 spent on assets. This is way below average. Nutra Pharma's management efficiency ratios could be used to measure how well Nutra Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Nutra Pharma Workforce Comparison
Nutra Pharma Corp is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 97.0. Nutra Pharma holds roughly 4.0 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of 28.71 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (5.58) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $5.58. Nutra Pharma Notable Stakeholders
A Nutra Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nutra Pharma often face trade-offs trying to please all of them. Nutra Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nutra Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Neil Roth | Inc Diagnostics | Profile | |
Dale MBA | Chief Officer | Profile | |
Erik Deitsch | CEO, Chairman | Profile | |
Nina Goldstein | Sec | Profile |
About Nutra Pharma Management Performance
The success or failure of an entity such as Nutra Pharma Corp often depends on how effective the management is. Nutra Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nutra management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nutra management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Please note, the presentation of Nutra Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nutra Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nutra Pharma's management manipulating its earnings.
Nutra Pharma Workforce Analysis
Traditionally, organizations such as Nutra Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nutra Pharma within its industry.Nutra Pharma Manpower Efficiency
Return on Nutra Pharma Manpower
Revenue Per Employee | 13K | |
Revenue Per Executive | 13K | |
Net Loss Per Employee | 192.3K | |
Net Loss Per Executive | 192.3K |
Complementary Tools for Nutra Pink Sheet analysis
When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |